Combining Serum Interleukin-6 and other Inflammatory Biomarkers to Improve the Prediction of COVID-19 Severity

Serum levels of tumor necrosis factor alpha and interferon alpha in COVID-19 patients and their correlations with disease severity.

Serum Levels of Intercellular Adhesion Molecule-1 and TNF- in Patients with COVID-19 and Its Relation to Disease Severity

Diagnostic Value of Serum Level of Interleukin 33 (IL-33), C-C Motif Chemokine Ligand 17 (CCL17) and Interferon Gamma Inducible Protein-10 (IP-10) in Coronavirus Disease 2019 (CO

Correlating COVID-19 Infection Severity and Prognosis with Cytokines Level

The integrating baseline inflammatory biomarker to enhance the forcasting of COVID-19 severity

Potential Diagnostic and Prognostic Values of Hematological Biomarkers in COVID-19‎ ‎

Cytokine Storm in COVID-19 Patients: Association between cytokines and disease severity

TNF-a and IL-10 Serum Levels in COVID-19 Patients and their Relation to Disease Severity

Interleukin-5, Interleukin-6 and Eosinophils in COVID-19 Egyptian Patients: Potential Clues for Prognosis and Immunotherapy